|
|
|
|
The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
|
|
Supporters of EVISA includes:
|
|
|
Glossary
enloplatin
Enloplatin is a platinum metallodrug developed for cancer therapy. Chemical Synonyms (1,1-cyclobutanedicarboxylato(2-)-O,O')(tetrahydro-4H-pyran- 4,4-dimethanamine-N,N') platinum(II) CL 287110, CL-287110 CAS Registry No. 111523-41-2
Back
|
|
|